ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1911

Targeting the Oxidative Stress Pathway in Experimental Spondyloarthritis Reduces Pro-inflammatory Response in Rat Macrophages and Modulates Their Metabolic Requirements

Fatemeh Navid1, Francesca LiCausi 1, Breanna Nguyen 1, Antony Cougnoux 2, Pierre-Christian Violet 3, Mark Levine 3 and Robert Colbert 1, 1NIAMS/NIH, bethesda, 2NICHDR/NIH, Bethesda, 3NIDDK/NIH, Bethesda

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: ROS and metabolism, Spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: 4M121: Spondyloarthritis Including Psoriatic Arthritis – Clinical IV: Axial Spondyloarthritis Translational Research (1908–1913)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: HLA-B27 is associated with the development of spondyloarthritis (SpA) and has a tendency to generate ER stress due to misfolding which can activate the unfolded protein response (UPR). UPR may contribute to SpA pathogenesis by promoting the production of pro-inflammatory cytokines like IL-23 and TNF. Under ER stress cells produce more reactive oxygen species (ROS), which further can worsen the UPR and promote inflammation. Our preliminary data indicate that IFNg and LPS treatment increases ROS and cytokine production to a greater extent in HLA-B27-expressing macrophages compared to wild type cells or cells expressing the non-disease associated allele, HLA-B7. Another important aspect of inflammation is that upon inflammatory activation immune cells have to change their metabolic requirements in order to meet the adequate response like producing pro-inflammatory cytokines. Here we examined whether reducing oxidative stress in HLA-B27+ macrophages affects pro-inflammatory cytokine production and UPR gene expression. Furthermore, we were interested whether targeting the oxidative stress pathway will modulate the metabolic requirements of the cells upon inflammatory activation.

Methods: Bone marrow derived macrophages from HLA-B27 and human b2m (hb2m) transgenic rats were examined with and without IFNg and LPS treatment. ROS levels were meseared with the ROS-sensitive dye MitoSOX for mitochondrial ROS production and 2’,7’-dichlorofluorescein diacetate (DCFDA) for cellular ROS level detection. N-acetylcysteine (NAC) was used as an antioxidant, and  differential gene expression was determined by RNASeq. For cytokine secretion, ELISAs were used and in order to measure metabolic activity the Seahorse Assay was performed. Wild type (WT) and HLA-B7/hb2m transgenic rat macrophages were used as controls.

Results: Bone marrow-derived macrophages from HLA-B27-transgenic (Tg) showed increased baseline mitochondrial ROS production in the absence of UPR compared to HLA-B7-Tg and wild type (WT) control rats. Further stimulation of HLA-B27-Tg macrophages with IFNg and LPS (stimulated) showed increased ROS production compared to HLA-B7-Tg and WT control rats.This was accompanied by robust activation of the UPR only in HLA-B27-expressing cells. Treatment with NAC, an ROS scavenger, significantly reduced ROS levels in HLA-B27+ macrophages and strongly decreased the transcription of many pro-inflammatory cytokines including Il-23, Il-12, Tnf, Il-6, Il-1a and Il-1b. The effect of NAC was further verified by ELISA assays available for rat IL-6 and TNF. NAC treatment had minimal effect on UPR gene expression, with partially reduction of BiP expression and no changes in HLA-B27 expression. Interestingly, NAC reduced metabolic activity in stimulated macrophages to levels similar to untreated control cells as measured by the Seahorse Assay.

Conclusion: Our data demonstrate that reducing ROS levels with NAC ameliorates ER stress-related pro-inflammatory effects of HLA-B27 misfolding. Alteration of the oxidative stress pathway should be further explored for therapeutic intervention in SpA.


Disclosure: F. Navid, None; F. LiCausi, None; B. Nguyen, None; A. Cougnoux, None; P. Violet, None; M. Levine, None; R. Colbert, None.

To cite this abstract in AMA style:

Navid F, LiCausi F, Nguyen B, Cougnoux A, Violet P, Levine M, Colbert R. Targeting the Oxidative Stress Pathway in Experimental Spondyloarthritis Reduces Pro-inflammatory Response in Rat Macrophages and Modulates Their Metabolic Requirements [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/targeting-the-oxidative-stress-pathway-in-experimental-spondyloarthritis-reduces-pro-inflammatory-response-in-rat-macrophages-and-modulates-their-metabolic-requirements/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/targeting-the-oxidative-stress-pathway-in-experimental-spondyloarthritis-reduces-pro-inflammatory-response-in-rat-macrophages-and-modulates-their-metabolic-requirements/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology